Get startedLog in
    Picture of Kalvista Pharmaceuticals logo

    KALV — Kalvista Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapMomentum Trap
    All News

    Brief: Kalvista Pharmaceuticals Enters Into Licensing Agreement With Pendopharm To Commercialize Sebetralstat For Hae In Canada

    Picture of Kalvista Pharmaceuticals logoKalvista Pharmaceuticals
    26/06/2025 12:00
    June 26 (Reuters) - Kalvista Pharmaceuticals Inc KALV.O:

KALVISTA PHARMACEUTICALS ENTERS INTO LICENSING AGREEMENT WITH PENDOPHARM TO COMMERCIALIZE SEBETRALSTAT FOR HAE IN CANADA

KALVISTA PHARMACEUTICALS INC: FINANCIAL TERMS OF AGREEMENT ARE NOT BEING DISCLOSED

Source text: ID:nBw79qG3La

Further company coverage: KALV.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Kalvista Pharmaceuticals

    See all news